Alternative Data for PetMeds
| Alternative Data | Value | 3m Change | Trend | Benchmark | |
|---|---|---|---|---|---|
| Job Posts | 2 | Sign up | Sign up | Sign up | |
| Sentiment | 100 | Sign up | Sign up | Sign up | |
| Webpage traffic | 977,000 | Sign up | Sign up | Sign up | |
| Employee Rating | 56 | Sign up | Sign up | Sign up | |
| Google Trends | N/A | Sign up | Sign up | Sign up | |
| Patents | N/A | Sign up | Sign up | Sign up | |
| App Downloads | 33 | Sign up | Sign up | Sign up | |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up | |
| Facebook Engagement | 10,519 | Sign up | Sign up | Sign up | |
| Facebook Followers | 209,790 | Sign up | Sign up | Sign up | |
| Instagram Followers | 66,605 | Sign up | Sign up | Sign up | |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up | |
| Stocktwits Mentions | 11 | Sign up | Sign up | Sign up | |
| Stocktwits Subscribers | 3,404 | Sign up | Sign up | Sign up | |
| Tiktok Followers | 10,300 | Sign up | Sign up | Sign up | |
| X Mentions | 8 | Sign up | Sign up | Sign up | |
| Youtube Subscribers | 2,210 | Sign up | Sign up | Sign up | |
| News Mentions | N/A | Sign up | Sign up | Sign up | |
| Customer reviews | N/A | Sign up | Sign up | Sign up | |
| Business Outlook | 35 | Sign up | Sign up | Sign up | |
| Linkedin Employees | 230 | Sign up | Sign up | Sign up |
About PetMeds
PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.
| Price | $2.46 |
| Target Price | Sign up |
| Volume | 109,420 |
| Market Cap | $53M |
| Year Range | $1.6 - $3.98 |
| Dividend Yield | 0% |
| PE Ratio | 257 |
| Analyst Rating | 0% buy |
| Industry | Pet Care |
In the news
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETSJanuary 6 - GlobeNewswire |
|
Canine Oral Chewable Tablets Market Analysis Report 2026-2032: End User Profiles, Dosing Cadence, Sales Modes, Distribution Channels, Life Stages, Ingredients, Packaging, Pricing, Product Types, RegionsJanuary 15 - GlobeNewswire |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '25 | 41M | 31M | 9.5M | -11M | -8.4M | -0.500 |
| Q3 '25 | 44M | 32M | 12M | -8.5M | -5.9M | -0.560 |
| Q2 '25 | 51M | 37M | 14M | -34M | 0 | -0.060 |
| Q4 '24 | 53M | 38M | 15M | -710,000 | 1.1M | -0.030 |
| Q3 '24 | 60M | 42M | 17M | 2.3M | 2.2M | 0.110 |
Insider Transactions View All
| Silvercape Investments Ltd filed to buy 2,579,696 shares at $3.2. August 14 '25 |
| Silvercape Investments Ltd filed to buy 2,478,696 shares at $3.2. August 4 '25 |
| NINA CAPITAL HOLDINGS INC. filed to buy 2,575,000 shares at $3.5. July 22 '25 |
| Silvercape Investments Ltd filed to buy 2,360,496 shares at $3.2. July 21 '25 |
| Silvercape Investments Ltd filed to buy 2,342,931 shares at $3.2. July 18 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
![]() |
ChewyCHWY |
$25.47 3.5% | 46 |
![]() |
PetcoWOOF |
$3.62 12.1% | 40 |
![]() |
BARKBARK |
$0.81 0% | 26 |
![]() |
ZoetisZTS |
$115.62 0.1% | 49 |
![]() |
ChewyCHWY |
$25.47 3.5% | 46 |
Read more about PetMeds (PETS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, tiktok followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - PetMeds
The Market Cap of PetMeds is $53M.
As of today, PetMeds' PE (Price to Earnings) ratio is 257.
Currently, the price of one share of PetMeds stock is $2.46.
The PETS stock price chart above provides a comprehensive visual representation of PetMeds' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling PetMeds shares. Our platform offers an up-to-date PETS stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, PetMeds (PETS) does not offer dividends to its shareholders. Investors interested in PetMeds should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of PetMeds are Chewy, Petco, BARK, Zoetis, and Chewy.



